Navigation Links
Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
Date:1/7/2008

promote insulin release by beta cells in response to elevated blood glucose levels. In addition, in preclinical studies, the GDIR stimulates the release of GLP and GIP, two incretins that are important for proper insulin regulation, which may enhance glucose homeostasis. GDIR stimulation has also been found to increase the levels and activity of intracellular factors thought to be involved in the preservation of beta cells. The GDIR is amenable to small molecule, orally active, drug development.

About Diabetes

Diabetes is a major worldwide disease. Based on 2003 data, the International Diabetes Federation estimated that in 2005 there were 194 million adults with diabetes worldwide, an increase of over 40% since 1995. Approximately 90%, or 175 million, of diabetics worldwide suffer from type 2 diabetes, the adult-onset form of the disease. Type 2 diabetes is characterized by inadequate response to insulin or inadequate secretion of insulin as blood glucose levels rise. Therapies for type 2 diabetes are directed toward correcting the body's inadequate response with oral or injectable medications, or directly modifying insulin levels by injection of insulin or insulin analogs. The worldwide market for diabetes medications exceeded $10 billion in 2004, of which oral drugs exceeded $6 billion.

About Arena Pharmaceuticals

Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for the treatment of obesity. Arena's broad pipeline of novel compounds targeting G protein-coupled receptors, an important class of validated drug targets, includes compounds being evaluated independently and with its partners, Merck & Co., Inc. and Ortho-McNeil Pharmaceutical, Inc.

Arena
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
2. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
3. Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa
4. VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA-2291 to Reduce Vascular Inflammation
5. Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate
6. Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference
7. Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury
8. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
9. QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena(TM) (ospemifene) to Treat Postmenopausal Vaginal Syndrome
10. Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program
11. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015  The quality function within ... ensure products meet quality standards at every stage of ... regulations, quality leaders also have the challenge of balancing ... Those who don,t effectively balance these priorities risk ... as marketplace failure and regulatory scrutiny. For ...
(Date:3/27/2015)... /PRNewswire/ - Medicure Inc. (the "Company") (TSXV:MPH, OTCQB:MCUJF) announces ... grant of an aggregate of 236,070 options to certain ... the Company pursuant to the Company,s Stock Option Plan. ... the tenth anniversary of the date of grant, 5,000 ... the date of grant and 50,000 are set to ...
(Date:3/27/2015)... , March 27, 2015 Biopharmaceutical Industry ... biopharmaceutical industry comes out on top as the country,s ... new report  from ndp│analytics. According to the  analysis ... (R&D) investment over the last decade, accounting for 27 ... A Short Video on Medicare Part ...
Breaking Medicine Technology:New Medical Device Quality Study Finds Regulatory Environment is Boosting Quality Spending, Especially for Large Companies 2Week in Review: The Latest from PhRMA 2
... SHENZHEN, China , May 6 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain,Drugstore Ltd. ... in China based on the number of directly operated stores,announced today ... March 31, 2010 , before the market opens on, Wednesday, May 19, ... ...
... SCOLR Pharma, Inc. (NYSE AMEX: DDD ... Agreement with RedHill Biopharma Ltd. an Israeli corporation, (RedHill), ... ondansetron tablet formulations based on SCOLR,s proprietary extended delivery ... Zofran®, GlaxoSmithKline,s drug to prevent chemotherapy and radiation related ...
Cached Medicine Technology:China Nepstar Chain Drugstore Reports First Quarter 2010 Results on May 19 2China Nepstar Chain Drugstore Reports First Quarter 2010 Results on May 19 3SCOLR Pharma, Inc. Enters into Worldwide Licensing Agreement with RedHill Biopharma Ltd. 2SCOLR Pharma, Inc. Enters into Worldwide Licensing Agreement with RedHill Biopharma Ltd. 3
(Date:3/28/2015)... New York, NY (PRWEB) March 28, 2015 ... clinic that offers urgent care in Manhattan, recently commemorated ... urgent care facility in Manhattan. In addition to 24-hour ... to ER facilities. , At this time, Emergency ... treatments for abdominal pain, asthma, chest pain, eye injuries, ...
(Date:3/28/2015)... 28, 2015 Pitching speed, player’s height, and ... shoulder and elbow injuries, according to new research released today ... ) Specialty Day. , “Our findings indicate that a 10 ... in likelihood of a history of injury, a 10 mile ... increase likelihood of a history of injury, and playing for ...
(Date:3/28/2015)... 2015 Early surgery may not be ... AC joint injuries, according to new research from Tripler ... American Orthopaedic Society for Sports Medicine’s ( AOSSM ) ... when surgery was not performed. , The final study ... treatment and 17 receiving non-surgical therapy. Of the non-surgery ...
(Date:3/28/2015)... Omaha, NE (PRWEB) March 28, 2015 ... leader in healthcare staffing, including physical therapy jobs, ... exhibitor at the Ohio Physical Therapy Association Annual ... the Renaissance Columbus Downtown Hotel in Columbus, OH. ... programming, networking opportunities, and exhibits with products and ...
(Date:3/28/2015)... ARDX will sponsor the 7th Annual Women’s Wellness ... Chesapeake Conference Center in Chesapeake, Virginia. Each year, ARDX ... women in the Hampton Roads region. The 2015 Women’s ... Women grow stronger through sharing their stories and learning ... the WWC™ theme is T-talk where we will share a ...
Breaking Medicine News(10 mins):Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2Health News:Researchers Highlight Shoulder and Elbow Injury Possibility in Youth Players 2Health News:For Type V AC Joint Injuries, Early Surgery May Not Be the Best Approach 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2
... ... wife and husband team of doctors, is a finalist in the Sixth Annual ... technologies, and Epocrates, the premier provider of medical decision support tools for doctors ... health blog until midnight Sunday, February 14. , ...
... ... Implementation of New Infrastructure Technologies. , ... (PRWEB) December 11, 2009 -- Data Strategy, a trusted leader of ... that helps customers evaluate the benefits of deploying Avamar deduplication backup software. SurePath ...
... , , CHICAGO , Feb. 11 ... a life-saving gift this Valentine,s Day by declaring disease-causing E. ... for them.   E. coli O157:H7 was declared ... the west coast outbreak that sickened over 700 people and killed ...
... , WESTPORT, Conn. , Feb. 11 ... resident and Zeta Interactive CEO, Al DiGuido , announced ... this evening from Aitoro,s Appliances in Norwalk, CT . , ... 2010, will feature live entertainment and dancing, top-quality dining from several ...
... , , NORFOLK, Va. Feb. 11 ... piloted his Cessna 208 Caravan to Santo Domingo, Dominican ... remarkable airlift of Operation Smile medical volunteers and supplies into Hinche, ... Mr. Ford decided to volunteer his time, piloting skills and aircraft ...
... study finds , THURSDAY, Feb. 11 (HealthDay News) -- A ... discharge a patient who has come to the emergency room ... artery calcium scoring (CACS) test detects coronary artery disease. A ... detailed image of the heart that shows calcium build-up in ...
Cached Medicine News:Health News:CelebrityDiagnosis.com Nominated as Best New Medical Blog of 2009 2Health News:CelebrityDiagnosis.com Nominated as Best New Medical Blog of 2009 3Health News:Data Strategy Announces SurePath Services Offering for EMC Avamar 2Health News:Data Strategy Announces SurePath Services Offering for EMC Avamar 3Health News:Six Other E. coli's Could Be Lurking In Your Valentine Day's Dinner 2Health News:Al's Angels' 'Love and Laughter' Event to Support Children and Families in Desperate Need 2Health News:Al's Angels' 'Love and Laughter' Event to Support Children and Families in Desperate Need 3Health News:Actor and Humanitarian Harrison Ford Assists Operation Smile's Relief Efforts in Haiti 2Health News:Actor and Humanitarian Harrison Ford Assists Operation Smile's Relief Efforts in Haiti 3Health News:Actor and Humanitarian Harrison Ford Assists Operation Smile's Relief Efforts in Haiti 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: